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ABSTRACT 
Mastitis is an inflammation of the mammary gland that costs the United States dairy 
industry between $1.7 and $2 billion annually [9]. Approximately 97% of mastitis 
infections are caused by bacteria, which can be treated with antibiotics [2]. However, 
mastitis infections can be caused by the alga, Prototheca. Specifically, it is P. zopfii 
(genotype 2) and P. blaschkeae that have been found in cows with mastitis [7].  There are 
currently no approved treatments for protothecal mastitis. The following experiments a 
tested the effects of grapefruit seed extract (GFSE) on P. zopfii (genotype 2) using 
spectrophotometry and plating techniques. GFSE was chosen because previous research 
has shown it has antimicrobial properties, it is water soluble, inexpensive, and has the 
potential to be a legal treatment. Prototheca isolation medium (PIM) broth was inoculated 
with P. zopfii colonies to 47% transmittance (T). Serial dilutions of GFSE were made 1:1 
with distilled water (DW) starting at 4,000ug/mL down to 125ug/mL. These dilutions 
were mixed 1:1 with 47% PIM and incubated for 72 hours. Absorbance readings were 
taken at 0, 24, 48, and 72 hours, and the samples plated on blood agar to evaluate the 
sterility of the samples.It was found that not even the highest concentration of GFSE was 
effective at inhibiting the P. zopfii (G2) colonies. However, this study does not preclude 
that GFSE may be effective against P. zopfii growth under different conditions. 
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INTRODUCTION 
Mastitis is an inflammation of the mammary gland that results in scarring of the 
mammary tissue, reduced milk production, and sometimes systemic illness [1]. Mastitis is 
seen most commonly in dairy cattle, and can be caused by physical trauma (about 1% of 
cases), or by an infection [1]. The organisms that cause this infection usually enter the 
udder through the teat canal [2]. The organisms kill the milk-secreting epithelial cells 
within the udder, which then slough off and are replaced with scar or connective tissue, 
thus leading to reduced milk production. Mastitis is separated in to four categories: 
peracute, acute, subacute, and subclinical [1]. Peracute mastitis presents as a swollen, hot, 
and red udder followed by systemic illness that includes fever, depression, shivering, 
weight loss, and sometimes death. Acute mastitis also includes severe udder 
inflammation, but less severe or no systemic signs. Subacute mastitis presents as a mildly 
infected udder, with no systemic illness. The least severe, subclinical, is when the 
mammary gland and cow show no outward signs, but when the milk is cultured and a 
somatic cell count (SCC) performed, the milk shows the presence of infectious organisms 
and an increase in SCC.  Mastitis infections can lower production rates on dairy farms by 
as much as 15-20% per infected animal [2], and some farms can have infection rates of 
up to 70% of the cattle.  
Decreased milk production, increased cost of treatments, and increased culling 
due to mastitis result in a dramatic decrease of profit for farmers. The biggest economic 
loss to farmers is from reduction in total milk produced. Consider a 500-cow herd that is 
averaging 50 lbs. milk/cow/day for 365 days per year. If they experience a 20% milk loss 
at a price of $16/100 lbs. of milk, in one year the farm would lose $58,400 due to mastitis 
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[2]. Mastitis incidence rates on well-managed farms are generally less than 20%, but 
some farms may have as many as 70% of the cattle with mastitis in at least one quarter of 
the udder at any one time.  
The largest portions of mastitis infections, approximately 95%, are caused by 
bacteria such as Streptococcus agalactiae, Staphylococcus aureus, Streptococcus 
dysgalactiae, Streptococcus uberis, Escherichia coli, and coagulase-negative 
Staphylococci [2]. Treatment options for bacterial mastitis infections include intra-
mammary infusions and systemic antibiotic treatments. Antibiotics that are approved for 
lactating dairy cows include amoxicillin, ampicillin, ceftiofur, cepharin, cloxacillin, 
erythromycin, hetacillin, novobiocin, penicillin G and  pirlimycin[15]. While these 
antibiotics are being used and for usually four to five  days afterwards [15], the milk 
cannot be sold for human consumption.  If caught selling contaminated milk the farm is 
rendered a severe financial penalty and must pay for the entire truck of contaminated 
milk. If a farm is found to violate residue laws three  times within a year, the milker’s 
permit is revoked [16]. The top reasons cited for residue violation are that the milker was 
too rushed, there was a new milker working that day, the treated cow just rejoined the 
milking herd, or there was a failure to mark the treated cows [15]. The costs of treatment, 
the money lost from milk withholding, and any accidental fines make treating bacterial 
mastitis still costly to the farmer.  
The other 5% of mastitis infections are caused by other organisms, including 
Prototheca. Prototheca is a colorless alga that persists in wet environments containing 
decaying organic matter such as feces or plants [10]. There are five different species of 
Prototheca, but only P. zopfii (gentoype 2) and P. blaschkeae have been found within the 
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milk secretions of dairy cows with mastitis [7]. There is currently no treatment for 
protothecal mastitis, and due to its negative effect on milk quality and production, culling 
is usually suggested for infected cows [10]. Culling results in decreases in profits for 
dairy farmers, due to the cost of replacing the cow. 
While the number of Prototheca-caused mastitis cases is not extremely high [10], 
the alga is resistant to current mastitis treatments and can be resistant to current 
pasteurization methods [12]. This study tests whether a naturally occurring fungicide can 
effectively kill common strains of Prototheca, in vitro. If so, steps could be made towards 
creating a viable treatment of protothecal mastitis, and thus Maine dairy farmers may 
eventually benefit by using an inexpensive treatment to avoid culling infected cattle.  
Studies of many different algaecides, including amphotericin B, nystatin, 
polymyxin B, gentamicin and neomycin, have been conducted on Prototheca [12]. These 
algaecides were all tested in vitro and most were successful at inhibiting the Prototheca 
species to some degree. However, farmers cannot legally use these algaecides in dairy 
cattle. Farmers do not wish to lose profit by throwing away milk, or risk receiving a large 
fine for sending milk containing antibiotics or other chemicals into the processing plant. 
Instead of treating a cow with protothecal mastitis, they would either milk the cow last to 
avoid spreading the infection to rest of the herd via milking equipment, or they would 
cull the infected animal. Use of good hygiene and culling infected animals is the best 
route to avoid the spread of infection. However, culling the infected animals can be costly 
to the farmer. Therefore, finding an inexpensive way to treat a prototheca infection that 
allows the milk to be sold soon after treatment would be the best way to return profits to 
Maine dairy farmers.   
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Effective methods of treating Prototheca should be based on the principles of 
action of antimicrobials known to be effective against related organisms.  Prototheca is 
closely related to yeast, which is a fungus containing ergosterol in its cell membrane. 
Ergosterol is a sterol similar in composition to cholesterol [4], providing support to the 
cell membrane. Compounds, such as amphotericin B [5], kill yeast by attaching to 
ergosterol and creating ion channels, a process called channel-mediated membrane 
permeabilization [5]. These channels allow ions to leak out of the cell, causing death of 
the cell via osmosis. The cell membrane of Prototheca is 4% ergosterol [11], suggesting 
that agents that kill yeast via ergosterol binding may also kill Prototheca species.  
A “natural” remedy suggested to treat yeast infections in humans is grapefruit 
seed extract (GFSE) [3]. Grapefruit seed extract (GFSE) has antibacterial properties when 
diluted as much as 1:512 with only 15 minutes contact time [6] against both gram 
negative and gram positive organisms. It has also been suggested to be effective against 
770 different types of bacteria and 93 different fungi [8].  The mechanism for GFSE 
activity against yeast is unknown, and some suggest it is not the GFSE that is effective 
against yeast, but possibly the preservative in commercially prepared GFSE [13]. 
Therefore, obtaining pure GFSE for experimentation purposes is ideal. The GFSE used in 
this experiment was purchased online, and while the package stated it was “Free of: 
sugar, soy, dairy, yeast, gluten, corn, and additives” there is no guarantee from the 
company that the GFSE is free of any chemicals from the processing.  
Given that GFSE has been reported to be antifungal, it may be effective against 
Prototheca growth. Ideally, any anti-protothecal mastitis treatment would be water 
soluble, which would allow it to spread throughout the mammary system after an 
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intramammary infusion. GFSE is at least slightly water soluble [6], and relatively 
inexpensive, making it a good candidate to test in the search for an anti-protothecal 
treatment.  
If GFSE is effective against P. zopfii growth during an in vitro trial, perhaps 
future trials can show positive in vivo effects. Ultimately, one would have to ensure that 
milk produced by a cow receiving GFSE treatment still follows the guidelines of the 
Pasteurized Milk Ordinance (PMO) set forth by the United States Public Health Service 
(USPHS).The ultimate goal of a practical Prototheca treatment is to effectively inhibit 
Prototheca growth, to have no impact on the milk quality, and to be inexpensive.  
 The objective was to test the efficacy of GFSE to prevent the growth of P.zopfii, 
in vitro. Our hypothesis was that GFSE will successfully inhibit P.zopfii (G2) growth 
because it appears to be effective against yeast, a close relative to Prototheca. 
MATERIALS AND METHODS 
Experiment 1 
The first step to the experiment was determining what concentration of GFSE 
would dissolve fully in water. We could then determine the starting point for the serial 
dilutions of GFSE treatments. Using a graduated cylinder, we measured out 100mL of 
water into a beaker. The GFSE powder used was purchased online from PureBulk, Inc. 
(Roseburg, Oregon). The lab analysis of the GFSE can be found in Appendix 1. We 
started by adding 1 gram of GFSE, and stirred well with a glass rod. We then centrifuged 
the solution for 5 minutes at 2500rpm. We found that a pellet formed at the bottom, and 
thus the GFSE did not fully dissolve in the water. We repeated the process with less 
GFSE until we found that we could dissolve 0.4grams of GFSE in the 100mL of water 
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without pellet formation. Thus, we decided that we should start with a stock 4000ug/mL 
GFSE solution for the serial dilutions.   
 
Experiment 2 
 Stock GFSE dilutions of 4000ug/mL, 2000ug/mL, 1000ug/mL, 500 ug/mL, 
250ug/mL and 125ug/mL were prepared using 1:1 serial dilutions in distilled water 
(DW). We started with 50mL of DW and added 0.2grams of GFSE, yielding a stock 
solution of 4,000ug/mL. We used a heating plate and a glass stirring rod to help dissolve 
the GFSE fully. The GFSE was heated to boiling temperature, or around 100oF. From this 
beaker we measured 25mL of the 4,000ug/mL solution into a graduated cylinder, and 
poured it into the next container. We added 25mL of DW, giving a new 2,000ug/mL 
solution. The container was inverted and shaken to ensure proper mixing. This dilution 
processed continued until we had 125ug/mL. The GFSE dilutions were then autoclaved 
to ensure sterility. 
A P. zopfii (genotype 2) sample was obtained from the American Type Culture 
Collection (ATCC). The isolate was stored on cryobeads at -80oC at The University of 
Maine. The P. zopfii was cultured on a Sabouraud dextrose agar (SDA) plate for 48hours 
at 28oC. A colony was examined under a microscope using a wet-mount to visually 
conclude that P. zopfii cultures were indeed  the organisms growing on the plate. If the 
organisms appeared colorless, spherical, and having multiple endospores like those seen 
in Figure 1, we concluded they were P. zopfii.  After confirming we had P. zopfii 
colonies, a single colony was picked and streaked onto another SDA plate for 96 hours at 
28oC.  
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Fig.1. P. zopfii colonies cultured and photographed in the University of Maine Animal Health 
Lab in Hitchner Hall at the University of Maine. 
 
 
Fig.2. Labeling of the glass tubes during the experiment. Tubes were covered in aluminum foil 
and autoclaved to ensure sterility. There were two trials of treatments performed, labeled 
Treatments 1 & 2. The PIM 47% and PIM 47%+Distilled Water tubes were positive controls 
(contained Prototheca). The PIM ONLY, GFSE ONLY, GFSE+PIM ONLY, and Distilled Water 
tubes were all negative controls (did not contain Prototheca).  
 
Autoclaved tubes were set up in racks and labeled according to Figure 2 (above). 
We had four negative controls (Pa-Pf, G1-G6, GP1-GP6, and the 6 DW tubes). There 
were 6mLs of autoclaved Prototheca Isolation Media (PIM) broth pipetted into each tube 
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Pa-Pf (36mLs total). The PIM broth was created for another experiment in 2012, and had 
been refrigerated since. The ingredient list can be found in Appendix 2. We expected the 
PIM ONLY tubes to remain at 0 absorbance after incubation when blanked with PIM, 
indicating no colony growth and therefore that the PIM broth was sterile. For the next 
negative control, there were 3mLs of each GFSE dilution pipetted into tubes G1-G6 
(18mLs total). These also served as negative controls, to ensure the sterility of the GFSE 
concentrations. For the third negative control, there were 3mLs each of GFSE dilution 
and 3mLs of autoclaved PIM broth pipetted into tubes GP1-6. These also serve as blanks 
in the spectrophotometer for the treatment tubes (A1A2-F1F2), because with the 
exception of P. zopfii colonies, the treatment tubes are the same as these negative 
controls. In the final negative control, 3mLs of autoclaved DW were pipetted into each 
DW tube (18mLs total), and used as a negative control to show the DW used throughout 
the experiment was sterile.  
We also used 2 positive controls for this experiment.  There were6mLs of PIM 
broth e pipetted in to tubes Ia-If. Using sterile loops, the PIM broth was inoculated with 
P. zopfii from the SDA plate. Using a PIM broth blank, the %Transmittance (%T) levels 
were read using a Bausch & Lomb Spectronic 20 spectrophotometer.  All readings for 
this experiment were done at 570nm, and every tube that entered the spectrophotometer 
was wiped clean with a KimWipe® to ensure there were no contaminants on the outside 
of the tube that may affect the readings. The tubes were stirred with the loop, then 
vortexed thoroughly using a Fisher Scientific Standard Vortex Mixer at speed 6 for 
approximately 30seconds-1minute.  The goal was to create a solution of roughly 47% T. 
The reason behind choosing 47% T was based on previous work done in the University 
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of Maine Animal Health Lab (UMAHL). The research showed that 47% T is equivalent 
to approximately 1x106 colony forming units (CFUs), which would have been useful if 
we decided to do any plate counts.  These 47% PIM tubes arethe positive controls, to 
ensure that the P. zopfii will grow in PIM broth after incubation.  
The other positive control was tubes X1-X6, which contained half 47% PIM broth 
and half DW. We needed this second positive control for two reasons. The first was to 
show that the broth and water combination used in the treatments could indeed grow P. 
zopfii. We suspect the P. zopfii will still grow in this diluted PIM broth solution because 
the P. zopfii is an alga with a thick cell wall, and thus will not be susceptible to such a 
change in osmolarity. The second reason for this positive control is it will provide 
appropriate absorbance readings to compare the treatments tubes to (which are half 47% 
Prototheca and half DW+GFSE), because we are unsure whether the P. zopfii would 
continue to proliferate well in a more hypotonic solution than the PIM broth.  
PIM broth (7mL) was then pipetted into six tubes (not pictured in Figure 1). 
Using a sterile loop, the PIM broth was inoculated with P. zopfii. Using a PIM blank, the 
T levels were read. All six tubes had exactly 47% T, or 0.33 absorbance (A).  The first 
tube of 7mL was vortexed and 3mL were pipetted into treatment tube A1, and 3mL more 
into tube A2. This was continued with all six tubes until all treatment tubes (A1A2-F1F2) 
contained 3mL of 47%T PIM. Then, 3mL of each corresponding GFSE dilution was 
pipetted into the treatment tubes and then vortexed thoroughly. The absorbance levels 
were read, using the corresponding GFSE+PIM control tubes (GP1-GP6) as blanks in the 
spectrophotometer.  
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All tubes were incubated at 28oC for 24 hours. The tubes were then vortexed and 
absorbance levels were read and recorded for all treatment tubes (A1A2-F1F2), as well as 
the 47% PIM controls (Ia-If), and the 47% PIM + DW (X1-X6). The samples then 
continued to incubate and absorbance readings were read and recording in the same 
fashion at 48 and 72 hours.  
 At 72 hours the GFSE+PIM dilution blanks (GP1-GP6), one of each treatment 
tube (A1-D1,E2,F1), and three of the PIM47% controls (Ia-Ic) were plated on blood agar 
plates, as diagrammed in Figure 2. We used 1uL loops to streak each 1/3 of the plates. 
These plates were then incubated at 34oC, and observed for colony forming units (CFU) 
at 24 and 48 hours. We expected to see no growth on the negative controls (GP1-GP6), 
solely P. zopfii growth on the positive controls (Ia-Ic), and if the GFSE had effectively 
killed the P. zopfii colonies, and no growth on the treatments (A1-D1, E2, F1) would 
indicate the GFSE had effectively killed the P. zopfii. At 72 hours we used wet-mounts 
under a microscope to observe any colony growth.  
 
Fig. 3. This is a diagram of the blood agar plates. We used sterile 1uL loops to streak each 1/3 of 
the plates. The plates were observed at 24, 48, and 72 hours for abnormal colony growth, which 
would indicate the solutions harbored organisms other than P. zopfii. At 72 hours any abnormal 
colonies were observed using a wet-mount under a microscope, and the assumed P. zopfii 
colonies from A1-E2, F1 and Ia-Ic were also checked under the microscope to ensure they were 
in fact P. zopfii colonies.  
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Experiment 3 
 
 This experiment was performed using the exact same procedures as Experiment 2, 
except the GFSE solutions were not autoclaved. Subjecting the GFSE to the extreme 
temperatures in the autoclave may have altered the components in the GFSE, therefore 
we used filtration to sterilize the GFSE rather than autoclaving it. The same serial 
dilutions of GFSE were made in DW as in Experiment 2. The solutions were then run 
through Corning Incorporated 0.2um sterile syringe filters into sterile tubes.  A single P. 
zopfii colony from the previously used cultures was streaked onto a fresh SDA plate and 
incubated for 48hours at 28oC.  
Once again, 2 sets of 6 sterile treatment tubes were set up in a rack (A3A4-F3F4). 
We created 6 more tubes with 7mL of 47% PIM broth from the colonies on the new SDA 
plate. We used the inoculating and spectrophotometry techniques from Experiment 2 to 
create a prototheca concentration of  47% T. From these 6 tubes, we pipetted 3mL of 
47% PIM into each of the 12 treatment tubes. We then pipetted 3mL of each filtered 
GFSE dilution into corresponding tubes. The tubes were then vortexed thoroughly and 
incubated for 72 hours at 28oC. 
As was done in Experiment 2, we then created individual blanks for the treatment 
tubes. We set up 6 tubes for blanks (GP1-GP6). We pipetted 3mL of sterilized PIM broth 
into them. Next we pipetted 3mL of the sterilized GFSE dilution into the blank tubes. We 
used these blanks for each corresponding GFSE treatment. Each tube placed in the 
spectrophotometer was wiped clean with a KimWipe®, and read at 570nm. We recorded 
the absorbance readings for the treatments using these blanks.  
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We also used the same positive and negative controls for this experiment as in 
Experiment 2. The positive controls to ensure sterility were once again 6 tubes of 6mLs 
of 47% PIM broth (Ia-If), and 6 tubes of 3mLs of 47%PIM : 3mL of DW (X1-X6). The 
negative controls were 6 tubes of 6mLs of sterilized PIM broth (Pa-Pf), and the 6 tubes of 
3mL of GFSE dilutions and 3mL of PIM broth (the blanks for the treatments).All 
samples were incubated at 28oC for 72 hours, and both and absorbance  readings were 
done at 24 hour intervals. 
At 72 hours the GFSE serial dilutions (4,000ug/mL – 125ug/mL), one of each 
treatment tube (A3, B4, C3, D4, E3, F4), and three of the PIM47% controls (Ia-Ic) were 
plated on blood agar plates, as diagrammed in Figure 4. We used 1uL loops to streak each 
1/3 of the plates. These plates were then incubated at 34oC, and observed for colony 
forming units (CFU) at 24 and 48 hours. We expected to see no growth on the negative 
controls (GP1-GP6), solely P. zopfii growth on the positive controls (Ia-Ic), and if the 
GFSE had effectively killed the P. zopfii colonies, there would also be no growth on the 
treatments (A3B4, etc). At 72 hours we used wet-mounts under a microscope to observe 
any colony growth.  
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Fig. 4.  This is a diagram of the blood agar plates. We used sterile 1uL loops to streak each 1/3 of 
the plates. The plates were observed at 24, 48, and 72 hours for abnormal colony growth, which 
would indicate the solutions harbored organisms other than P. zopfii. At 72 hours any abnormal 
colonies were observed using a wet-mount under a microscope, and the assumed P. zopfii 
colonies from A1-E2, F1 and Ia-Ic were also checked under the microscope to ensure they were 
in fact P. zopfii colonies. 
 
 
RESULTS 
Experiment 2 
Figure 5 shows that the absorbance of the first positive control, the 47% PIM, 
continued to increase linearly over the course of incubation.  
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Fig. 5. The absorbance of the positive control, 47% PIM, continued to increase over the 72 hours 
of incubation. Only the average of the six controls (Pa-Pf) has been graphed, and a linear best-fit 
line was applied.  
 
The other positive control used in this experiment was 47% PIM + DW (X1-X6) 
in a 1:1 ratio.  Similar to the previous positive control, only the average of the absorbance 
readings was graphed. As seen in Figure 6, the absorbance readings increased in a linear 
fashion, with an R2 value of 0.999 and a slope of 0.00224 A/hr.  
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Fig. 6. The average absorbance readings for the positive controls (X1-X6) increased in a linear 
fashion over the 72 hours of incubation. The linear best-fit line has an R2 value of 0.999 and an 
equation of y=0.00224x + 0.1495. The slope of these absorbance readings will be compared to 
the slopes of the treatment tubes (A1A2-F1F2).  
 
As seen in Figure 7, the absorbance of the GFSE treatments increased during 
incubation. The absorbances of the two trials of each treatment concentration were 
averaged before being graphed. Linear best-fit lines using Microsoft Excel were applied 
to each GFSE treatment absorbance reading (not pictured). The 47% positive control was 
also graphed. The slope values of each GFSE treatment were compared to the slope 
values of the 47% PIM + DW positive control in Table 1.  
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Fig. 7. The absorbance readings for two trials of each treatment were averaged and then graphed. 
The GFSE treatment absorbances increased linearly during incubation. The positive control is 
graphed for comparison, and the best-fit linear line is shown to emphasize the general slope. The 
slopes of the best-fit lines are compared to that of the positive control in Table 1.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
0 
0.05 
0.1 
0.15 
0.2 
0.25 
0.3 
0.35 
0 24 48 72 
A
b
so
rb
an
ce
 a
t 
5
7
0
 n
m
 
Hours 
Absorbance of GFSE Treatments and Positive 
Control 
2000ug/mL 
1000ug/mL 
500ug/mL 
250ug/mL 
125ug/mL 
62.5ug/mL 
Positive Control 
Linear (Positive Control) 
 
 
17 
 
 
 
       
Table 1. Comparing the slopes of the absorbance readings of the treatments to the slopes of the 
absorbance readings of the 47% PIM + DW controls.  
47% PIM + 
DW Controls 
Slope 
(A/hr) 
#STD Away 
from Mean 
Treatments Slope  
(A/hr) 
# STD Away 
from Mean 
Average 
X1 0.00208 -1.468 2000ug/mL 0.00200 -0.106 
0.615 
X2 0.00221 -0.266 2000ug/mL 0.00238 1.337 
X3 0.00238 1.337 1000ug/mL 0.00192 -3.071 
-2.269 
X4 0.00233 0.936 1000ug/mL 0.00208 -1.468 
X5 0.00221 -0.266 500ug/mL 0.00179 -4.272 
-2.269 
X6 0.00221 -0.266 500ug/mL 0.00221 -0.266 
    
Average 0.002236  250ug/mL 0.00196 -2.670 
-0.066 
Standard 
Deviation 
0.000104 
 250ug/mL 0.00250 2.538 
    
   125ug/mL 0.00217 -0.667 
0.135 
   125 ug/mL 0.00233 0.936 
    
   62.5ug/mL 0.00233 0.936 
0.935897 
   62.5 ug/mL 0.00233 0.936 
 
 
The slope values for 47%PIM + DW treatments were calculated using Excel. The average and 
standard deviation were found. The slopes of the treatments were then calculated in a similar 
manner, and compared to the standard deviation of the control. The numbers of standard 
deviations from the mean of the two similar treatments were then averaged.  
  
 The % T and A readings of the negative control, PIM ONLY broth, (Pa-Pf) 
showed no change after incubation.  
The blood agar plate with Ia-Ic showed growth in all three thirds. All the colonies 
were uniform (small, greyish-clear colonies), and upon examination under a microscope 
using a wet mount, they appeared to be P. zopfii as they appeared similar to those shown 
in Figure 1. There was a single yellowish colony in Ic, that was considered to be a 
contaminant from the plating process, as it was not widespread throughout the plate. 
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 The blood agar plates with GP1-GP6 showed no growth, except another small 
yellowish colony in GP2. This also was considered to be a contaminant from the plating 
process as well, as there was just a single colony.  
 The final blood agar plates, containing A1-D1, E2, and F1, showed what appeared 
to be solely P. zopfii growth (small, greyish clear colonies). Upon examination under the 
microscope using a wet-mount they appeared to be P. zopfii.  
 
Experiment 3 
 Comparable to Experiment 2, the absorbance readings of the positive control, 
47% PIM, increased linearly over time in Figure 8. The exponential trend line did not 
seem to fit as accurately as in Experiment 2 (see Figure 4), as indicated by the R2 value.  
  
Fig. 8. The absorbance for the positive controls in Experiment 3 also continued to increase over 
time. The linear trend-line did not fit as well, as indicated by the R2 value, and the data suggests 
the P. zopfii colonies grew extremely fast during the initial 24 hour incubation period.  
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 Figure 9 shows the absorbance readings of the 47% PIM + DW increasing 
linearly, as in Experiment 2. Again, a best-fit linear line was applied, and the slope value 
was compared to that of the GFSE treatments.  
 
 
Fig. 9. The absorbance readings for 47% PIM + DW increased in a linear fashion during 
incubation. This slope is used in comparison with the treatments from Experiment 3. 
 
Figure 10 contains the absorbance readings from the GFSE treatments. The slopes 
of the linear best-fit lines from Figure 10 are compared to the positive control slope (also 
pictured). These comparisons are seen in Table 2.  
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Fig. 10. The absorbance readings of the GFSE treatments increase linearly over the incubation 
period. The slopes of the best-fit lines are compared to the slope of the best-fit line of the positive 
control, 47% PIM + DW. This is included on the graph, and a best-fit line has been applied.  
 
Table 2.  
47% PIM 
+ DW 
Controls 
Slope 
(A/hr) 
#STD 
Away 
from 
Mean 
Treatments 
Slope  
(A/hr) 
# STD 
Away 
from 
Mean 
Average 
X1 0.00317 -1.693 2000ug/mL 0.003583 -0.1722 
-0.1722 
X2 0.00366 0.14 2000ug/mL 0.003583 -0.1722 
X3 0.00356 -0.2419 1000ug/mL 0.003333 -1.0879 
-0.7821 
X4 0.004 1.362 1000ug/mL 0.0035 -0.4762 
X5 0.00363 -0.01273 500ug/mL 0.004083 1.65934 
0.82051 
X6 0.00375 0.4456 
500ug/mL 0.003625 -0.0183 
250ug/mL 0.0035 -0.4762 
-0.5531 
Average 0.00363   250ug/mL 0.003458 -0.63 
Standard 
Deviation 
0.000273 
  
125ug/mL 0.0035 -0.4762 
0.28755 
125 ug/mL 0.003917 1.05128 
    62.5ug/mL 0.003667 0.13553 
0.36447 
    62.5 ug/mL 0.003792 0.59341 
 
 
The slope values for 47%PIM + DW treatments were calculated using Excel. The average and 
standard deviation were found. The slopes of the treatments were then calculated in a similar 
manner, and compared to the standard deviation of the control. The numbers of standard 
deviations from the mean of the two similar treatments were then averaged. 
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 The PIM ONLY tubes from Experiment 3 showed no change in absorbance, and 
thus were considered sterile.  
The blood agar plate with Ia-Ic showed what appeared to be a lawn of P. zopfii 
colonies after 48 hours of incubation. There were no other colonies other than the small, 
white greyish ones associated with P. zopfii. The blood agar plates with the standard 
stock solution showed no colony growth.  The final blood agar plates, containing the 
treatments (A3B4, etc) also showed a lawn of P. zopfii-like growth, and no other 
colonies.  
 
DISCUSSION AND CONCLUSION 
Experiment 2 
Figure 5 and theblood agar plate results illustrate that PIM broth facilitates the 
growth of P. zopfii. The increasing absorbance suggests the P. zopfii continued to 
increase in turbidity, thus increasing in numbers after incubation. Also, once Ia-Ic were 
plated on blood agar, all the colonies appeared to be P. zopfii colonies, and the 
absorbance readings were not due to the growth of other colonies. The other positive 
control, the 47% PIM + DW also showed an increase in absorbance levels after 
incubation, as shown in Figure 6. This indicates the P. zopfii was able to proliferate in a 
more hypotonic solution than just PIM broth. When the slopes of the 47%T PIM and 
47%T PIM + DW are compared, there is very little difference, although it appears the 
additional water may have slowed the P. zopfii growth slightly. Thus, we can conclude 
the P. zopfii was able to proliferate when the 47% PIM was combined in a 1:1 ratio with 
DW, and we now have absorbance readings to compare the GFSE treatments to.  
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The PIM ONLY tubes, one of the negative controls, showed no change in 
absorbance, indicating sterility. Another negative control, the GFSE+PIM broth (GP1-
GP6), once plated on blood agar, proved to be sterile (except for the single contaminant 
assumed to be from plating). The blood agar plates were used instead of SDA or PIM 
plates because blood agar plates facilitate the growth of most all organisms. Therefore, 
they would be a better indicator of contamination over SDA or PIM plates that only 
facilitate growth of certain organisms. This means the GFSE treatments were all sterile, 
and that GP1-GP6 were appropriate blanks for the GFSE treatment tubes (A1A2-F1F2). 
We can also infer the GFSE negative controls (G1-G6) were sterile (since they came 
from the same stock GFSE solutions as the GP1-GP6 tubes), so we did not plate them on 
blood agar.  
Figure 7 indicates that P. zopfii continued to proliferate in PIM broth regardless of 
the presence of GFSE.  When compared to the positive control, it appears the slope of the 
GFSE treatments is similar to that of the control, even though the y-intercepts are quite 
different. We believe this was due to improper mixing of the 47% PIM before it was 
pipetted into the treatment tubes. Also, it can be inferred from the plating of the GFSE 
treatment tubes that the organisms that were continuing to grow were indeed P. zopfii, 
and not some contaminant. Table 1 allows us to infer that the presence of the GFSE, in 
any of the tested concentrations, had no effect on the P. zopfii growth. 
Table 1 shows the calculated best-fit slopes of the positive control, 47% PIM 
+DW. The average of these slopes was found, as well as the standard deviation. The 
slopes of the treatment tubes were also found, and compared to the average slope of the 
controls by using the standard deviations. Typically, anything within 2 standard 
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deviations is considered within the “normal” limits. The slope of the highest 
concentration of GFSE has an average # of standard deviations of less than 1from the 
mean, meaning it is not different from that of the control. This means the growth rate of 
the P. zopfii subjected to the highest level of GFSE is not different from the growth rate 
of the P. zopfii control. The 1,000ug/mL and 500ug/mL treatments have an average # of 
standard deviations from the mean of over 2. This would make us assume the growth rate 
of the P. zopfii in these treatments is different from that of the control. However, because 
the higher concentration did not seem to inhibit P. zopfii growth, it seems unusual for a 
lower concentration to slow the growth rate. We believe these results are due to the fact 
we only have 2 trials of the treatments, and it is likely that with more trials the average 
slope would be within 2 standard deviations from the slope of the controls. The lower 
concentration treatments are all also within 1 standard deviation of the control, 
suggesting the growth rate of the P. zopfii in the treatments are similar to the growth rate 
of the P. zopfii the control. However, with our limited number of trials we do not have 
enough data to accurately perform a statistical analysis. 
Experiment 3 
The difference between Experiment 2 and Experiment 3 was  that the GFSE 
concentrations were sterilized with a syringe filter instead of being autoclaved. Figure 7 
and the blood agar plates illustrate the PIM broth supported the growth of the P. zopfii. 
The absorbance readings increased linearly during incubation, and once Ia-Ic were plated 
on blood agar, it was shown the colonies were all P. zopfii. Theother positive control, the 
47% PIM + DW also showed increasing absorbance levels after incubation, as shown in 
Figure 8. Thus, we can conclude the P. zopfii was able to proliferate when the 47% PIM 
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was combined in a 1:1 ratio with DW, and we had absorbance readings to compare the 
GFSE treatments to.  
The PIM ONLY tubes, one of the negative controls, did not show any change in 
absorbance after incubation. This means the PIM media was sterile, and the filtration did 
indeed sterilize the GFSE solutions. Once we plated the serial dilutions of GFSE on 
blood agar, they showed no culture growth. This means the filters also worked to sterilize 
the GFSE treatments. 
The information in Figure 10 confirmed P. zopfii continued to proliferate in the 
PIM broth regardless of the presence of GFSE because the absorbance readings continued 
to increase after incubation.  Also, it can be inferred from the plating of the GFSE 
treatment tubes that the organisms that were continuing to grow were indeed P. zopfii, 
and not some contaminant. The absorbance rates were increasing in a nearly identical 
fashion for all treatments, thus suggesting that the presence of the GFSE did not affect the 
growth rate. Table 2 allows us to infer that the presence of the GFSE, in any of the tested 
concentrations, had no effect on the P. zopfii growth. 
Table 2 shows the calculated best-fit slopes of the positive control, 47% PIM 
+DW. The average of these slopes was found, as well as the standard deviation. The 
slopes of the treatment tubes were also found, and compared to the average slope of the 
controls by using the standard deviations. Once again, anything within 2 standard 
deviations is considered within the “normal” limits. The highest concentration of GFSE 
has an average # of standard deviations of less than 1, meaning it considered similar to 
the control. This means the growth rate of the P. zopfii subjected to the highest level of 
GFSE is not different from  the growth rate of the P. zopfii control. In fact, if you look at 
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slopes all of the treatments, they are all within 1 standard deviation of the average of the 
controls. Thus, it is safe to say, the growth rate of the P. zopfii in all the treatment tubes 
was equivalent to that of the growth rate in the positive control 47% PIM + DW, and thus 
the GFSE concentrations had no effect on the growth rate of the P. zopfii.  
Experiment 3 was run because we realized we may have rendered the 
antimicrobial compounds in the GFSE inactive when we autoclaved it in Experiment 2. 
We autoclaved the GFSE because we did not know if it was sterile or not, and did not 
want other organisms to grow in the PIM broth and effect the spectroscopy results. 
However, we neglected to realize that by heating the GFSE solutions to 212oF, we were 
possibly inactivating compounds within the GFSE. Thus, while there was technically 
GFSE in with the P. zopfii, there is a possibility the GFSE was no longer capable of 
killing the P. zopfii. Instead of autoclaving the GFSE solutions, we decided to redo the 
experiment, and to run the GFSE dilutions through a 0.2micron filter. The filter would 
“catch” any bacteria, and thus sterilize the GFSE without denaturing any compounds 
within it. However, it was simply a hypothesis that we rendered the GFSE ineffective by 
autoclaving it.  
Realistically, there is a chance the GFSE compounds were still intact during 
Experiment 2, and we realized that we did not have a control to prove whether the GFSE 
was rendered ineffective. However, it was noted that the color of the GFSE after being 
filtered was much lighter than the autoclaved GFSE. We are unsure of whether this is 
because autoclaving the GFSE darkened the color (thus suggesting the compounds may 
have been affected by autoclaving), or if perhaps the filters were catching enough of the 
GFSE to cause a reduction in color. The filters did indeed prevent a significant amount of 
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GFSE from passing through, as indicated by the difficulty in pushing down the plunger of 
the syringe, and by the filter turning slightly reddish in color. Whether the filters were 
catching the “active ingredients” in the GFSE is unknown, thus the concentrations of 
GFSE in Experiment 3are not guaranteed accurate due to the filtering process. However, 
the colors indicated there was indeed more GFSE in the highest concentration treatment, 
and we can say the growth rate of the P. zopfii did not appear different from that of the 
treatment in Experiment 3.  
Overall, the data does not support our hypothesis that GFSE inhibits the growth of 
P. zopfii. There are three main reasons why we may have obtained the data we did. 
Firstly, perhaps GFSE does not have any antimicrobial properties at all. Many researchers 
have suggested that it is the chemicals used to extract the GFSE that can cause it to be 
antimicrobial against other bacteria and fungi [13], not the actual compounds found in the 
GFSE. To determine this we should have run the experiment on bacteria that are easier to 
kill than the algae P. zopfii, such as E. coli. If we had done this during Experiment 2 with 
the autoclaved GFSE, and the GFSE inhibited E. coli growth, then we would have known 
the GFSE does have some form of antimicrobial properties. We also would have known 
the GFSE was still activated after it was autoclaved and thus would not have had to run 
Experiment 3. 
If the GFSE was effective against the E. coli and not the P. zopfii, we would know 
that the concentrations of GFSE used were simply ineffective against the wall or some 
other aspect of the P. zopfii cells. This would be the second reason why we obtained the 
results we did.  
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Another possibility is that perhaps we were not using a high enough concentration 
of GFSE to effectively kill the P. zopfii. We attempted to use the highest concentration 
that would fully dissolve into the DW. However, we also could have used a different 
solvent to increase the concentration of the GFSE. This tactic may have resulted in a 
solution that is not a viable treatment for intramammary infusion for dairy cattle mastitis, 
because the treatment would not disperse well through the water (milk) in the cow’s 
udder. Thus, we did not explore this experimental route. Alternatively, we could have 
altered the pH of the solution to increase the amount of GFSE that would dissolve in 
solution. Because the pH of the GFSE solution was between 4-7, that means the GFSE is 
slightly acidic. Had we added a base to the DW, we could have increased the amount of 
GFSE that could be dissolved in the DW and thus increased the concentration. However, 
we would have wanted to keep the pH between 5 and 7, because this is the optimum pH 
for P. zopfii growth.  
Future research would require ensuring the GFSE does indeed have some 
antimicrobial properties, by testing it against some bacteria such as E. coli. If the GFSE is 
found to possess antimicrobial properties, we could attempt to increase the GFSE 
concentration using buffers.  Once the highest concentration is reached and tested against 
the P. zopfii, we could attempt to use a different solvent to increase the concentration 
even more to sufficiently support or disprove the if GFSE is effective against Prototheca 
growth. As mentioned, the only problem with this is the solvent may not be sufficient for 
intramammary injection.  
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DATA TABLES 
Experiment 2 
 
Table 3.    Absorbance (A) of GFSE treatments 
Treatments A at 0 hours A at 24 hours A at 48 hours A at 72 hours 
A1 0.06 0.12 0.18 0.2 
A2 0.07 0.15 0.21 0.24 
B1 0.07 0.13 0.17 0.21 
B2 0.1 0.17 0.22 0.25 
C1 0.08 0.13 0.17 0.21 
C2 0.08 0.15 0.2 0.24 
D1 0.08 0.12 0.17 0.22 
D2 0.1 0.17 0.23 0.28 
E1 0.11 0.19 0.23 0.27 
E2 0.19 0.26 0.31 0.36 
F1 0.08 0.16 0.21 0.25 
F2 0.1 0.21 0.26 0.32 
The spectrophotometer was blanked with GP1-GP6 for each corresponding dilution of 
GFSE (A1,A2-F1,F2). The spectrophotometer was set to 570nm. Based on the continual 
decrease of T, it can be concluded that the prototheca continued to grow, and thus the 
different concentrations of GFSE had no effect on protothecal growth. 
 
 
 
 
 
 
Table 4.    Absorbance of 47% PIM 
47% PIM A at 0 hours A at 24 hours A at 48 hours A at 72 hours 
Ia 0.34 0.35 0.44 0.48 
Ib 0.33 0.37 0.45 0.5 
Ic 0.335 0.4 0.46 0.51 
Id 0.33 0.42 0.45 0.54 
Ie 0.34 0.43 0.45 0.55 
If 0.33 0.39 0.45 0.5 
The spectrophotometer was blanked with PIM broth and was set to 570nm. Based on the 
continual increase of A, it can be concluded that the prototheca continued to grow, and 
thus was a successful positive control. 
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Table 5.    Absorbance of 47% PIM + Distilled Water 
47% PIM + DW A at 0 hours A at 24 hours A at 48 hours A at 72 hours 
X1 0.15 0.2 0.25 0.3 
X2 0.15 0.2 0.25 0.31 
X3 0.15 0.21 0.27 0.32 
X4 0.15 0.21 0.26 0.32 
X5 0.15 0.2 0.25 0.31 
X6 0.15 0.2 0.25 0.31 
The spectrophotometer was blanked with 3mL of PIM broth and 3mL of distilled water 
and was set to 570nm. Based on the continual increase of A, it can be concluded that the 
prototheca continued to grow, and thus was a successful positive control. 
 
 
 
 
 
 
 
Table 6.    Absorbance of PIM ONLY 
 PIM ONLY A at 0 hours A at 24 hours A at 48 hours A at 72 hours 
Pa 1 N/A 1 N/A 
Pb 1 N/A 1 N/A 
Pc 1 N/A 1 N/A 
Pd 1 N/A 1 N/A 
Pe 1 N/A 1 N/A 
Pf 1 N/A 1 N/A 
The spectrophotometer was blanked with PIM broth and was set to 570nm. Based on the 
consistent absorbency readings, it can be inferred that: there was no growth within the 
PIM broth, and thus was a successful positive control. 
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Experiment 3 
 
 
Table 7.    Absorbance (A) of GFSE treatments 
Treatments A at 0 hours A at 24 hours A at 48 hours A at 72 hours 
A1 0.17 0.3 0.38 0.43 
A2 0.17 0.3 0.38 0.43 
B1 0.16 0.3 0.35 0.41 
B2 0.16 0.3 0.36 0.42 
C1 0.16 0.32 0.4 0.46 
C2 0.17 0.32 0.38 0.44 
D1 0.17 0.31 0.37 0.43 
D2 0.17 0.32 0.37 0.43 
E1 0.16 0.31 0.37 0.42 
E2 0.17 0.33 0.4 0.46 
F1 0.16 0.31 0.28 0.43 
F2 0.16 0.32 0.39 0.44 
The spectrophotometer was blanked with GP1-GP6 for each corresponding dilution of 
GFSE (A1,A2-F1,F2). The spectrophotometer was set to 570nm. Based on the continual 
decrease of T, it can be concluded that the prototheca continued to grow, and thus the 
different concentrations of GFSE had no effect on protothecal growth. 
 
 
 
 
 
 
Table 8.    Absorbance of 47% PIM 
47% PIM A at 0 hours A at 24 hours A at 48 hours A at 72 hours 
Ia 0.33 0.5 0.6 0.66 
Ib 0.33 0.5 0.61 0.64 
Ic 0.33 0.5 0.59 0.64 
Id 0.33 0.5 0.56 0.62 
Ie 0.33 0.5 0.58 0.64 
If 0.33 0.5 0.56 0.64 
The spectrophotometer was blanked with PIM broth and was set to 570nm. Based on the 
continual increase of A, it can be concluded that the prototheca continued to grow, and 
thus was a successful positive control. 
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Table 9.    Absorbance of 47% PIM + Distilled Water 
47% PIM + DW A at 0 hours A at 24 hours A at 48 hours A at 72 hours 
X1 0.16 0.28 0.35 0.4 
X2 0.16 0.28 0.35 0.4 
X3 0.15 0.27 0.33 0.38 
X4 0.15 0.28 0.34 0.4 
X5 0.16 0.28 0.34 0.4 
X6 0.16 0.27 0.33 0.37 
The spectrophotometer was blanked with 3mL of PIM broth and 3mL of distilled water 
and was set to 570nm. Based on the continual increase of A, it can be concluded that the 
prototheca continued to grow, and thus was a successful positive control. 
 
 
 
 
 
 
 
 
 
 
Table 10.    Absorbance of PIM ONLY 
 PIM ONLY A at 0 hours A at 24 hours A at 48 hours A at 72 hours 
Pa 1 N/A N/A 1 
Pb 1 N/A N/A 1 
Pc 1 N/A N/A 1 
Pd 1 N/A N/A 1 
Pe 1 N/A N/A 1 
Pf 1 N/A N/A 1 
The spectrophotometer was blanked with PIM broth and was set to 570nm. Based on the 
consistent absorbency readings, it can be inferred that: there was no growth within the 
PIM broth, and thus was a successful positive control.
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APPENDIX 1 
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APPENDIX 2 
ATCC medium: 1371 Prototheca isolation medium (PIM) 
 
Potassium hydrogen phthalate......10.0 g 
NaOH...............................0.9 g 
MgSO4 ..............................0.1 g 
KH2PO4 .............................0.2 g 
NH4Cl ..............................0.3 g 
Glucose...........................10.0 g 
Thiamine . HCl.....................0.001 g 
Agar..............................20.0 g 
5-Fluorocytosine*..................0.25 g 
Distilled water to.................1.0 L 
Adjust pH to 5.1 +/- 0.1 and autoclave at 121C for 15-20 
minutes. 
*May be left out of medium for routine maintenance. 
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